Corporate news

Procleix® Zika Virus Assay Approved by the FDA for Blood Screening on the Procleix® Panther® System Procleix Zika Virus assay provides U.S. blood banks the ability to screen blood donations for the presence of the Zika virus and improve blood transfusion safety
+ info

Grifols achieves key milestone with FDA approval of the new Consolidated Manufacturing Facility (CMF) for production of recombinant proteins Grifols' investment opens up growth opportunities in contract development and manufacturing services to current and future customers.
+ info

Grifols expands its plasma collection network by acquiring 24 Biotest centers in the United States The transaction aligns with Grifols' corporate strategy and enables the company to reinforce its donation-center expansion plan
+ info



We are a solid company with an international dimension.

Corporate Commitment

We contribute to improving people's health and wellbeing by offering safe, high quality products produced using the latest environmentally friendly technology.

When a Dream Comes True. An Illustrated History of 75 Years of Grifols

Read When a Dream Comes True: An illustrated history of 75 years of Grifols to discover the company's roots, and learn more about our history and the development of the company.  + info


get to know us better